The researchers found that a two or more years’ supply of PPIs and a two or more years’ supply of H2RAs are associated with an increased risk for B12 deficiency. The researchers concluded that risks and benefits of these medications should be weighed before use.
The study’s authors include Douglas A. Corley, MD, PhD; Wei Zhao, MPH; Jennifer L. Schneider, MPH; and Jameson R. Lam, MPH.
More Articles on Gastroenterology:
ASGE Recognizes 6 Endoscopy Centers for Safety & Quality
The Changing Healthcare Environment & Gastroenterologists: Q&A With Dr. Edwin Levine
Long Island Digestive Disease Consultants Selects PriorityOne Group for IT
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
